ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,432.69
0.54%
Brent Oil
83.825
0.28%
Bitcoin
66,713.67
0.66%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aethlon Medical Inc (AEMD)

  7. Aethlon Medical Inc (AEMD) News

Aethlon Medical (AEMD)

Aethlon Medical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AEMD
DateTimeSourceHeadlineSymbolCompany
17/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
17/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
17/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
16/05/202421:05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:AEMDAethlon Medical Inc
16/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
15/05/202414:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AEMDAethlon Medical Inc
15/05/202414:15PR Newswire (US)Aethlon Medical Announces Pricing of $4.7 Million Public OfferingNASDAQ:AEMDAethlon Medical Inc
13/05/202422:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AEMDAethlon Medical Inc
10/05/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
10/05/202413:01PR Newswire (US)Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaNASDAQ:AEMDAethlon Medical Inc
21/02/202413:01PR Newswire (US)Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesNASDAQ:AEMDAethlon Medical Inc
14/02/202422:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AEMDAethlon Medical Inc
14/02/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
14/02/202421:15PR Newswire (US)Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
07/02/202413:00PR Newswire (US)Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024NASDAQ:AEMDAethlon Medical Inc
02/01/202423:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
02/01/202423:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
02/01/202423:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
22/12/202321:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AEMDAethlon Medical Inc
27/11/202312:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
14/11/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
14/11/202321:15PR Newswire (US)Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
13/11/202313:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
13/11/202313:01PR Newswire (US)Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating OfficerNASDAQ:AEMDAethlon Medical Inc
06/11/202313:01PR Newswire (US)Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023NASDAQ:AEMDAethlon Medical Inc
10/10/202313:01PR Newswire (US)Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in OncologyNASDAQ:AEMDAethlon Medical Inc
04/10/202322:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
04/10/202313:01PR Newswire (US)Aethlon Announces Reverse Stock SplitNASDAQ:AEMDAethlon Medical Inc
29/09/202322:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
29/09/202322:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
 Showing the most relevant articles for your search:NASDAQ:AEMD

Your Recent History

UPBT
XELBTC
Elastic
LSE
INRU
Am Msci Indiaii
COIN
UECBTC
USOTC
KKPT
KoKo Petroleum (CE)
TG
PKX
POSCO
LSE
0NJB
Snp Schneider Neureither...
BIT
P1LSX2
BNP Paribas Issuance
LSE
47UW
Anz Bank 46
BIT
P1JUG7
BNP Paribas Issuance
COIN
GTNUST
GlitzKoin
NASDAQ
NSTG
NanoString Technologies
LSE
0IR4
Auga Group Ab
KUCN
QRDOETH
Qredo Token
NASDAQ
CDX
CARDIODX INC
COIN
UPTKGBP
Universal Protocol Token
USOTC
AKPJS
Ark7 Properties Plus (GM)
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved